Our findings revealed that HERC1 gene expression was severely downregulated both in acute and in chronic myelogenous leukemia at diagnosis, while it is restored after complete remission achievement. The gene discussed is HERC1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.